Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.


Company Details

Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071
Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071
Telephone: +64-6-390-6938
Facsimile: n/a
Website: www.ruabio.com
First Listed: 22/10/2020
Balance Date: 30 June
AGM: 12/10/2022

Directors and Executives

Tony Barclay
Independent Director
Panapa Ehau
Executive Director
Teresa Farac-Ciprian Independent Non-Executive Director
Brett Gamble
Non-Executive Director
Paul Naske
Chief Executive Officer
Anna Stove
Chair
Hamish White
Chief Financial Officer

Announcements

Title Date Type
Capital Change Notice Thu, May 15 2025 08:30 am SECISSUE
Rua approves debt facility to accelerate sales. Tue, May 13 2025 03:58 pm CORPACT
Rua Bioscience reports record six month sales Wed, Apr 30 2025 08:47 am MKTUPDTE
Record Sales in March for New Zealand Mon, Mar 31 2025 08:30 am MKTUPDTE
Rua Bioscience Half Year Results data Mon, Mar 03 2025 08:30 am GENERAL
Rua Bioscience Half Year Results - Global Growth Fri, Feb 28 2025 08:30 am HALFYR
Capital Change Notice Fri, Feb 14 2025 10:24 am SECISSUE
Revenue exceeds previous forecast Tue, Jan 28 2025 09:13 am MKTUPDTE
Revenue exceeds previous forecast Tue, Jan 28 2025 08:57 am MKTUPDTE
Psilocybin clinical trial update Tue, Jan 21 2025 01:29 pm MKTUPDTE

Major Holdings Announcements

Date Name No. Held % Current
22/12/22 Michael John Wilding 8,509,556 - 5.39
18/03/22 Hikurangi Enterprises Limited 8,132,620 - 5.43
17/03/22 Hikurangi Bioactives Limited Partne 4,000,000 12.58 2.67
22/10/20 Tailorspace Capital Limited, Tailor 11,129,375 - 7.95
22/10/20 Fang Group Investment Limited and F 23,584,939 - 16.85
22/10/20 Andrew Charles Williams 7,756,838 - 5.54

Director’s Interests Announcements

Date Name No. Held % Details Other
31/05/23 Hamish White 80,895 - - -
17/05/23 Antony George Barclay 50,000 - - -
02/11/21 Paul Naske 159,872 - - -
02/11/21 Rob Mitchell 288,251 - - -
02/11/21 Panapa Ehau 474,224 - - -
02/11/21 Trevor Burt 958,002 - - -
22/10/20 Martin Smith 2,544,732 - - -
22/10/20 Brett Gamble 1,805,914 - - -
22/10/20 Anna Stove 763,896 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 06/06/2023


Markets News

Restaurant Brands ‘does not seem to care’: Shareholder
Retail

Restaurant Brands ‘does not seem to care’: Shareholder

At the fiery annual meeting, a shareholder called the Californian market a ‘sinkhole’.

Infrastructure

Channel increases dividend, mulls ASX listing

Dividend up from 11c to between 12c and 12.5c. 

Channel increases dividend, mulls ASX listing
Property

Oceania CEO hopes sales cadence eases investor concerns

Suzanne Dvorak is "very positive" sales momentum will continue. 

Oceania CEO hopes sales cadence eases investor concerns
Markets The Small Cap Wrap

Which small cap is off to Aussie? Plus results, and more

PaySauce, Blis, Aroa, Foley Wines, John McMahon, and more.

Which small cap is off to Aussie? Plus results, and more
Markets Market Close

NZX down as My Food Bag sees green shoots

No apparent impact from Budget 2025 announcements on NZX.

Tom Raynel 22 May 2025
NZX down as My Food Bag sees green shoots